卫光生物(002880.SZ)：签订《血液制品技术合作合同》

Core Viewpoint - Weigao Bio (002880.SZ) is set to sign a technical cooperation contract for blood products, emphasizing mutual benefit and common development with its partner [1] Group 1: Financial Details - The technical licensing fee is set at $12 million, while the technical transfer service fee is $4 million, totaling $16 million [1] - The total amount of $16 million is approximately 113.21 million RMB, based on the exchange rate published by the People's Bank of China on December 1, 2025 [1]